Valle d’Aosta

Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi

DOI: https://doi.org/10.7175/fe.v9i1S.1000

Abstract

In Aosta Valley region 77,9% of women (aged 25-64) are screened regularly, meaning every 3 years.
Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 2 cases of cervicocarcinoma and 1 related death and thus results to be cost-effective (33.211 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 1 cancer case could be prevented, with a very similar cost-effectiveness ratio. In Aosta Valley region, the net cost for woman vaccinated is 209 € for the single cohort and 211 € for the multiple cohort.

Keywords

Aosta Valley; HPV vaccination; Economic & clinical impact

Full Text

PDF

Statistics

Abstract: 334 views
PDF: 102 views

Refbacks

  • There are currently no refbacks.




© SEEd srl